Mode of Action of the Mitochondrial Clinical-stage Drug Candidate KH176: Two Birds, One Stone

NIJMEGEN, Netherlands, April 26, 2018 /PRNewswire/ -- Khondrion, a leading clinical-stage pharmaceutical company focusing on small molecule therapeutics for mitochondrial diseases, today announced the publication of a scientific article reporting on the development and unique mode of...

from PR Newswire: //https://ift.tt/2HLPvhV